Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02053181
Status:
COMPLETED
Last Update Posted:
2014-02-03
First Post:
2014-01-30
Brief Title:
Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
A Phase 1 Open-label Single Oral Dose Study to Investigate the Pharmacokinetics Safety and Tolerability of Cadazolid in Patients With Severe Clostridium Difficile Infection CDI
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study investigated the pharmacokinetics safety and tolerability of cadazolid in subjects with severe Clostridium difficile diarrhea CDAD and whether this influenced the quantity of cadazolid absorbed into the systemic circulation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None